Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the effect of lipid-lowering therapy (LLT) in primary prevention on cardiovascular disease (CVD) and death in type 1 diabetes. RESEARCH DESIGN AND METHODS: We used the Swedish National Diabetes Register (NDR) to perform a propensity score–based study. Propensity scores for treatment with LLT were calculated from 32 baseline clinical and socioeconomic variables. The propensity score was used to estimate the effect of LLT in the overall cohort (by stratification). We estimated risk of acute myocardial infarction, stroke, coronary heart disease, and cardiovascular and all-cause mortality in individuals with and without LLT using Cox regression. A total of 24,230 individuals included in 2006–2008 NDR with type 1 diabetes without a history of CVD were followed until 31 December 2012; 18,843 were untreated and 5,387 treated with LLT (97% statins). The mean follow-up was 6.0 years. RESULTS: The propensity score allowed balancing of all 32 covariates, with no differences between treated and untreated after accounting for propensity score. Hazard ratios (HRs) for treated versus untreated were as follows: cardiovascular death 0.60 (95% CI 0.50–0.72), all-cause death 0.56 (0.48–0.64), fatal/nonfatal stroke 0.56 (0.46–0.70), fatal/nonfatal acute myocardial infarction 0.78 (0.66–0.92), fatal/nonfatal coronary heart disease 0.85 (0.74–0.97), and fatal/nonfatal CVD 0.77 (0.69–0.87). CONCLUSIONS: This observational study shows that LLT is associated with 22–44% reduction in the risk of CVD and cardiovascular death among individuals with type 1 diabetes without history of CVD and underlines the importance of primary prevention with LLT to reduce cardiovascular risk in type 1 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to the situation for blood pressure, there is a paucity of trials of lipid-lowering therapy in people with type 1 diabetes, but an observational study reported that lipid-lowering therapy is associated with a 22-44% reduction in the risk of cardiovascular disease and death among individuals with type 1 diabetes without a prior history of cardiovascular disease (48).”
In the citing paper
“Similar benefits were seen in both T1DM and T2DM.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [253]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055 · cited 1×
“Sensitivity and specificity for diagnoses of acute myocardial infarction (AMI), coronary heart disease (CHD), hospitalization for heart failure, atrial fibrillation, and stroke have been validated (12,13).”
BackgroundStamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · cited 1×
“There are studies, both interventional and observational, proving that hyperlipidemia has a crucial role in the process of atherosclerosis and development of CVD (17,18).”
BackgroundStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationMortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389
Self-citationRawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A.-M., Eliasson, B., & Gudbjörnsdottir, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31506-x · Cited by 802
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 172
Rawshani, A., Rawshani, A., Sattar, N., Franzén, S., McGuire, D. K., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., Rosengren, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037454 · Cited by 177
Self-citationCardiovascular Risk in Type 1 Diabetes Mellitus
Schofield, J., Ho, J., & Soran, H. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0612-8 · Cited by 150
Colom, C., Rull, A., Sánchez‐Quesada, J. L., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081798 · Cited by 118
BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
Edqvist, J., Rawshani, A., Adiels, M., Björck, L., Lind, M., Svensson, A.-M., Gudbjörnsdottir, S., Sattar, N., & Rosengren, A. (2019) · Diabetes Care · doi:10.2337/dc18-1446 · Cited by 99
Self-citationPrevention of Cardiovascular Disease in Type 1 Diabetes
Manrique‐Acevedo, C., Hirsch, I. B., & Eckel, R. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311526 · Cited by 79
Goldberg, R. B., Stone, N. J., & Grundy, S. M. (2020) · Diabetes Care · doi:10.2337/dci19-0036 · Cited by 58
Shah, V. N., Bailey, R. J., Wu, M., Foster, N. C., Pop‐Busui, R., Katz, M. L., Crandall, J. P., Bacha, F. F., Nadeau, K. J., Libman, I. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa015 · Cited by 60
Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids
Semova, I., Levenson, A. E., Krawczyk, J., Bullock, K. H., Gearing, M. E., Ling, A. V., Williams, K., Miao, J., Adamson, S. S., Shin, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.120.045373 · Cited by 47
Zhang, Y., Gu, Y., Jiang, J., Cui, X., Cheng, S., Liu, L., Huang, Z., Liao, R., Zhao, P., Yu, J.-Y., et al. (2022) · npj Science of Food · doi:10.1038/s41538-022-00156-0 · Cited by 41
Yang, X. H., Zhang, B. L., Cheng, Y., Fu, S. K., & Jin, H. M. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.07.018 · Cited by 43
Reduced HDL function in children and young adults with type 1 diabetes
Heier, M., Borja, M. S., Brunborg, C., Seljeflot, I., Margeirsdottir, H. D., Hanssen, K. F., Dahl‐Jørgensen, K., & Oda, M. N. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0570-2 · Cited by 38
Melin, E. O., Thulesius, H. O., Hillman, M., Landin‐Olsson, M., & Thunander, M. (2018) · BMC Obesity · doi:10.1186/s40608-018-0193-5 · Cited by 43
Viñals, C., Conget, I., Pané, A., Boswell, L., Perea, V., Blanco, J., Ruiz, S., Giménez, M., Vinagre, I., Esmatjes, E., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3320 · Cited by 35
Goldberg, R. B. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.011 · Cited by 34
Lipid management for cardiovascular risk reduction in type 1 diabetes
Tell, S., Nadeau, K. J., & Eckel, R. H. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000551 · Cited by 30
Schweiger, D. Š., Battelino, T., & Grošelj, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910192 · Cited by 30
Dei, A., Aldigeri, R., Mantovani, A., Masulli, M., Palmisano, L., Cavalot, F. L., Bonomo, K., Baroni, M. G., Cossu, E., Cavallo, M. G., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad127 · Cited by 23
Macedoni, M., Hovnik, T., Plesnik, E., Kotnik, P., Bratina, N., Battelino, T., & Grošelj, U. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.04.013 · Cited by 22
Viñals, C., Conget, I., Granados, M., Giménez, M., & Amor, A. J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01616-4 · Cited by 19
Xie, W., Huang, H., Xiao, S., Yang, X., & Zhang, Z. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105057 · Cited by 18
Yoo, J., Jeon, J., Baek, M., Song, S. O., & Kim, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04691-6 · Cited by 18
Amor, A. J., Ortega, E., Giménez, M., Cofán, M., Blanco, J., Pané, A., Boswell, L., Vinagre, I., Esmatjes, E., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.02.004 · Cited by 19
Hero, C., Karlsson, S. A., Franzén, S., Svensson, A., Miftaraj, M., Guðbjörnsdóttir, S., Sundell, K. A., Eliasson, B., & Eeg‐Olofsson, K. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000719 · Cited by 17
Self-citationKosteria, I., Schwandt, A., Davis, E. A., Jali, S. M., Prieto, M., Rottembourg, D., & the SWEET study group (2019) · Diabetic Medicine · doi:10.1111/dme.13963 · Cited by 18
Hero, C., Karlsson, S. A., Franzén, S., Svensson, A., Miftaraj, M., Guðbjörnsdóttir, S., Sundell, K. A., Eliasson, B., & Eeg‐Olofsson, K. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01115-w · Cited by 18
Self-citationCortés, V., & Eckel, R. H. (2022) · Circulation · doi:10.1161/circulationaha.122.058883 · Cited by 16
Cardiovascular risk management in type 1 diabetes
Teoh, I. H., Elisaus, P., & Schofield, J. D. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01400-9 · Cited by 15
Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences
Vurallı, D., Jalilova, L., Alikaşifoğlu, A., Özön, Z. A., Gonc, E. N., & Kandemir, N. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-12-12 · Cited by 17
Schnell, O., Valensi, P. E., Standl, E., & Ceriello, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.129 · Cited by 15
Paliares, I. C., Dualib, P. M., Torres, L. S. N., Aroucha, P. M. T., de Almeida-Pititto, B., de Sá, J. R., & Dib, S. A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02460-3 · Cited by 14
Lan, N. S. R., Bell, D. A., Watts, G. F., & Fegan, P. G. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000790 · Cited by 13
Shi, M., Tang, R., Huang, F., Zhong, T., Chen, Y., Li, X., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3423 · Cited by 15
All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes
Putula, E., Kauppala, T., Vanhamäki, S., Haapakoski, J., Laatikainen, T. K., & Metso, S. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108881 · Cited by 14
Amor, A. J., Vinagre, I., Valverde, M., Urquizu, X., Meler, E., López, E., Quirós, C., Giménez, M., Codina, L., Conget, I., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3362 · Cited by 13
Boswell, L., Serés‐Noriega, T., Mesa, A., Perea, V., Pané, A., Viñals, C., Blanco, J., Giménez, M., Vinagre, I., Esmatjes, E., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01959-z · Cited by 12
Karmali, R., Sipko, J., Majid, M., & Bruemmer, D. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01866-x · Cited by 11
Kawasaki, E., Fukuyama, T., Kuriyama, E., Uchida, A., Sagara, Y., Tamai, H., Nakano, Y., Tojikubo, M., & Koga, N. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13271 · Cited by 11
Ritsinger, V., Hero, C., Svensson, A., Saleh, N., Lagerqvist, B., Eeg‐Olofsson, K., & Norhammar, A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316687860 · Cited by 11
Self-citationCosson, E., Auzanneau, M., Aguayo, G., Karges, W., Riveline, J., Augstein, P., Sablone, L., Jehle, P., Fagherazzi, G., & Holl, R. W. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02419-4 · Cited by 9
Ritsinger, V., Hero, C., Svensson, A., Saleh, N., Lagerqvist, B., Eeg‐Olofsson, K., & Norhammar, A. (2018) · Diabetes Care · doi:10.2337/dc17-2352 · Cited by 12
Self-citationPorto, A. D., Candido, R., Rocca, A., Manicardi, V., Nicolucci, A., Miranda, C., Cimino, E., Bartolo, P. D., Cianni, G. D., & Russo, G. T. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02327-0 · Cited by 10
Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes
Blais, J. E., Yan, V. K. C., Chan, E. W., Wong, I. C. K., & Wan, E. Y. F. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.013 · Cited by 7
Remnant Cholesterol: From Pathophysiology to Clinical Implications in Type 1 Diabetes
Sebastián‐Valles, F., Muñiz, Á. M., & Marazuela, M. (2025) · Endocrines · doi:10.3390/endocrines6030046 · Cited by 6
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus
AlHabeeb, W., Elasfar, A., Kinsara, A. J., Aljizeeri, A. H., Jelaidan, I., Alghalayini, K. W., AlKheraiji., M. F., Akbar, M. A. J., Lawand, S., Alyousif, S. M., et al. (2024) · Journal of the Saudi Heart Association · doi:10.37616/2212-5043.1407 · Cited by 11
Avdic, T., Eliasson, B., Rawshani, A., Borén, J., Gerstein, H. C., Nordanstig, J., Rihawi, M., Beckman, J. A., McGuire, D. K., Ömerovic, E., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100852 · Cited by 6
Self-citationCurrent Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes
Ganda, O. P., & Mitri, J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0790-1 · Cited by 6
Diabetes is a cardiovascular disease, isn’t it?
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.006 · Cited by 6
Kamiński, M., Kulecki, M., Kasprzak, D., Lachowski, P., Kulczycka, A., Kozłowska, M., Klause, D., Naskręt, D., Flotyńska, J., Zozulińska‐Ziółkiewicz, D., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103853 · Cited by 5
Elian, V., Dorita, A., Stegaru, D., & Vinereanu, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178558 · Cited by 6
Kaser, S., Dobrev, D., Rocca, B., Kaski, J. C., Agewall, S., & Drexel, H. (2025) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaf023 · Cited by 3
Risk Factors for Premature Death in Diabetes Patients who Undergo Amputations below Ankle Level
Fabricius, T. W., Jansen, R. B., Jørgensen, B., & Svendsen, O. L. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-109700 · Cited by 3
Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
Marx, N., Federici, M., Schütt, K. S., Müller‐Wieland, D., Ajjan, R., Antunes, M. J., Christodorescu, R., Crawford, C. A., Angelantonio, E. D., Eliasson, B., et al. (2024) · Giornale Ialiano di Cardiologia · doi:10.1714/4162.41558 · Cited by 6
Self-citationLan, N. S. R., Ryan, C. D., Rudén, A., Glasby, J. R. K., Nanayakkara, N., Elghattis, Y., Brazionis, L., Huang, M., Lum, S., Januszewski, A. S., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70276 · Cited by 3
Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction
Serés-Noriega, T., Aguiló-Lafarga, I., Perea, V., Viñals, C., & Amor, A. J. (2026) · Annals medicus · doi:10.1080/07853890.2026.2642404 · Cited by 2
Clinical Care of Lipids in People with Type 1 Diabetes
Lan, N. S. R., Jenkins, A. J., & Fegan, P. G. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_28 · Cited by 3
Welters, A., Reinauer, C., Schwab, K. O., Boettcher, C., Hess, M., Bartelt, H., Dost, A., Rosenbauer, J., Galler, A., & Holl, R. W. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70610 · Cited by 1
Lundholm, M. D. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112682 · Cited by 1
Rawshani, A., Rawshani, A., Sattar, N. A., Franzen, S., McGuire, D. K., Eliasson, B., Svensson, A., Zethelius, B., Miftaraj, M., Rosengren, A., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.10.17 · Cited by 1
Self-citationAmor, A. J., Ortega, E., Giménez, M., Cofán, M., Blanco, J., Pané, A., Boswell, L., Vinagre, I., Esmatjes, E., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.09.001 · Cited by 1
Bujang, M. A., Tiong, X. T., Sapri, F. E., Ismail, M., Mustafa, F. I., & Hamid, A. M. A. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0686-2 · Cited by 1
Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes
O’Carroll-Lolait, A., Urwin, A., Doughty, I., Schofield, J. D., Thabit, H., & Leelarathna, L. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02434-w
Type 1 diabetes mellitus and cardiovascular risk: A short review
Kitsios, K., Trakatelli, C., Sarigianni, M., Kyriazidou, Α., Aroutsidis, F., Mastrogiannis, Κ., & Kotsis, V. (2022) · Journal of Atherosclerosis Prevention and Treatment · doi:10.53590/japt.02.1039
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Wilson, D. P., Hamilton, L., & Maki, K. C. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_14
Chen, X., Yu, J., Liu, Y., Wang, X., Ping, F., Li, W., Zhang, H., Xu, L., & Li, Y. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/1933825
D’Ardes, D., Bianconi, V., Dalt, L. D., D’Onofrio, L., Macchi, C., Visco, V., Cappelluti, M. A., Parrotta, I., Greco, C., Bencivenga, L., et al. (2025) · European Atherosclerosis Journal · doi:10.56095/eaj.v4i1.89
Blais, J. E., Yan, V. K. C., Chan, E. W., Wong, I. C. K., & Wan, E. Y. F. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119521
Cardiovascular Outcome Trials in Type 1 Diabetes: We Are Not There Yet
Hirsch, I. B., & Eckel, R. H. (2025) · Diabetes Care · doi:10.2337/dci25-0062
Fériz, K., Corral, P., Iriarte-Durán, M. B., Giraldo, C. M. G., Nardelli, N., Arias‐Valderrama, O., & Gómez-Ayala, M. C. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01613-2
Zhang, Z., Zhao, L. Y., Wang, Z., Zhou, X., Li, X. X., Yang, W., & Xu, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70491 · Cited by 1
Cardiovascular Disease and Dyslipidemia in Pediatric Type 1 Diabetes
Kim, G. K., Brar, P. C., & Bansal, N. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01409-z · Cited by 1
Prognosis of Type 1 Diabetes in Finland and its Determinants
Keisala, E. (2026) · Tampere University Institutional Repository (Tampere University)
Liu, C., Renström, F., Gastaldi, G., Brändle, M., & Bilz, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1819019
Holt, R. I. G., DeVries, J. H., Fischl, A. H., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, É., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06833-z · Cited by 1
Type 1 diabetes and cardiovascular medicine
Jenkins, A. J., Huang, M., Hemphill, M., Chen, D., Ha, J. T., Sata, Y., Sindone, A. P., Gnanenthiran, S. R., & Lan, N. S. R. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00338-9
Metadata
- Authors
- Hero, C., Rawshani, A., Svensson, A.-M., Franzén, S., Eliasson, B., Eeg-Olofsson, K., & Gudbjörnsdottir, S.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Swedish National Diabetes Register, Gothenburg, Sweden
- Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
- Corresponding author
- Hero, Christel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-04-18
- Volume
- 39
- Issue
- 6
- Pages
- 996-1003
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2337090699
- Cited by
- 78
- References
- 22
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 12 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 1
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- lipid-lowering therapy, type 1 diabetes, statins, cardiovascular disease, cardiovascular mortality, all-cause mortality, acute myocardial infarction, stroke, coronary artery disease, primary prevention, cardiovascular risk reduction
- MeSH terms
- Adult, Cardiovascular Diseases, Cause of Death, Coronary Disease, Diabetes Mellitus, Type 1, Female, Humans, Hyperlipidemias, Male, Middle Aged, Myocardial Infarction, Registries, Risk Factors, Sweden, Proportional Hazards Models, Case-Control Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke, Young Adult, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.